Joint Formulary & PAD

Buspirone hydrochloride - Anxiety

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Buspirone for the treatment of generalised anxiety disorders and to relieve the symptoms of anxiety with or without accompanying symptoms of depression.

Primary Care may initiate on specialist mental health team recommendation.

An Information Sheet has been provided to support prescribers in primary care.

Documents :
 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Buspirone hydrochloride
Indication :
Anxiety
Group Name :
Keywords :
GAD, generalised anxiety disorders
Brand Names Include :
Important Information :
Latest Additions Date From :
15 Jan 2026
Latest Additions Date To :
20 Feb 2026
Guidelines :
Supporting Documents :
2

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed to add buspirone to formulary for the treatment of generalised anxiety disorders and to relieve the symptoms of anxiety with or without accompanying symptoms of depression.

A Blue traffic light status was agreed whereby Primary Care may initiate on specialist mental health team recommendation.

An Information Sheet has been provided to support prescribers in primary care.

Other Indications

Below are listed other indications that Buspirone hydrochloride is used to treat.

  • No records returned.